KARNATAKA LOCKDOWN NEWS
-
Bengaluru firm seeks nod to test stem cell drug
A Bengaluru stem cell-based R&D and drug development firm has sought permission from the Drug Controller General of India (DCGI) to test a drug on Covid-19 patients in India.
Advertisement
Advertisement